Analysis of Humoral and Cellular Immunity of Lung Transplant Recipients Following SARS-CoV-2 Infection and BNT162b2 mRNA Vaccination

PURPOSE: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in lung transplant recipients (LTxR) under immunosuppression carries higher risk with 14-39% mortality. Immune responses of LTxR under immunosuppression following SARS-CoV-2 infection or vaccination remains unknown. Our goal is t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bansal, S., Fleming, T., Tiffany, B., Smith, M., Bremner, R., Mohanakumar, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
(294)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988698/
http://dx.doi.org/10.1016/j.healun.2022.01.315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988698/
http://dx.doi.org/10.1016/j.healun.2022.01.315

Ejemplares similares